Hagens Berman Notifies Dentsply Sirona (NASDAQ: XRAY) Investors of Securities Fraud Lawsuit and February 19, 2019 Lead Plaintiff Deadline


San Francisco - Hagens Berman Sobol Shapiro LLP notifies investors in Dentsply Sirona Inc. of the February 19, 2019 Lead Plaintiff deadline in the securities class action pending in the United States District Court for the Eastern District of New York.

If you (a) purchased or otherwise acquired shares of Dentsply Sirona, Inc. (NASDAQ: XRAY) between February20, 2014 and August 7, 2018 (the “Class Period”) OR (b) held Dentsply International, Inc. (“Dentsply Intl.”) shares as of December 2, 2015 and were entitled to vote with respect to Dentsply Intl.’s acquisition of Sirona Dental Systems, Inc. and suffered losses contact Hagens Berman Sobol Shapiro LLP.  For more information visit:


or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing


On February 29, 2016, Dentsply Intl. and Sirona Dental Systems, Inc. completed their merger to form Dentsply Sirona Inc.

On August 7, 2018, Dentsply Sirona announced its second quarter 2018 financial results.  In addition to news that it recorded a goodwill and intangible impairment charge of $1.265 billion, management slashed adjusted EPS guidance for 2018 to the range of $2.00 to $2.15 per share, down from its previous estimate of $2.55 to $2.65 per share.

This news drove the price of Dentsply Sirona shares down as much as $9.03, or about 18.5%, to close at $39.41 on August 7, 2018.

“We’re focused on investors’ losses and management’s historical statements about the Company’s Technologies and Equipment segment and certain distributor relationships,” said Hagens Berman partner Reed Kathrein.

Whistleblowers:  Persons with non-public information regarding Dentsply Sirona should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.  Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 510-725-3000 or email XRAY@hbsslaw.com.

# # #

About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 80+ attorneys in 10 offices across the country.  The Firm represents investors, whistleblowers, workers and consumers in complex litigation.  More about the firm and its successes can be found at www.hbsslaw.com.  For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.

Back to all cases


Please fill out the form below and we will get back to you as soon as we can.
*Required Field
Please list the date, quantity and share price of your purchases/sales during the Class Period so that we can calculate your losses. *
Upload your trade information. *

Case videos

Case Gallery

Case Timeline

10/05/17: Investigation